Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mesenchymal Stem Cells Market

4. Market Overview
    4.1. Introduction
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Mesenchymal Stem Cells Market Analysis and Forecast, 2017–2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. List Of Major Research Institutes Involved In Mesenchymal Stem Cells Studies
    5.3. Mesenchymal Stem Cells: Current Trends and Future Prospects in a Variety of Disease Conditions
    5.4. Regulatory Scenario by Region/globally
    5.5. COVID-19 Pandemic Impact on Industry

6. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Products & Services
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Products & Services, 2017–2031
        6.3.1. Product
            6.3.1.1. Workflow Type
            6.3.1.2. Product Type
        6.3.2. Services
    6.4. Market Attractiveness Analysis, by Products & Services

7. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Type, 2017–2031
        7.3.1. Autologous
        7.3.2. Allogenic
    7.4. Market Attractiveness Analysis, by Type

8. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Source of Isolation
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Source of Isolation, 2017–2031
        8.3.1. Bone Marrow
            8.3.1.1. Adipose
            8.3.1.2. Cord Blood
            8.3.1.3. Peripheral Blood
        8.3.2. Dental Pulp
        8.3.3. Others (lung tissue, umbilical cord tissue, etc.)
    8.4. Market Attractiveness Analysis, by Source of Isolation

9. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Indication
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by Indication, 2017–2031
        9.3.1. Musculoskeletal Diseases
        9.3.2. Cardiovascular Diseases
        9.3.3. Neuro Disorders
        9.3.4. Autoimmune Diseases
        9.3.5. Cancer
        9.3.6. GvHD
        9.3.7. Pulmonary Diseases
        9.3.8. Others
    9.4. Market Attractiveness Analysis, by Indication

10. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region

11. North America Mesenchymal Stem Cells Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Products & Services, 2017–2031
        11.2.1. Product
            11.2.1.1. Workflow Type
            11.2.1.2. Product Type
        11.2.2. Services
    11.3. Market Value Forecast, by Type, 2017–2031
        11.3.1. Autologous
        11.3.2. Allogenic
    11.4. Market Value Forecast, by Source of Isolation, 2017–2031
        11.4.1. Bone Marrow
            11.4.1.1. Adipose
            11.4.1.2. Cord Blood
            11.4.1.3. Peripheral Blood
        11.4.2. Dental Pulp
        11.4.3. Others (lung tissue, umbilical cord tissue, etc.)
    11.5. Market Value Forecast, by Indication , 2017–2031
        11.5.1. Musculoskeletal Diseases
        11.5.2. Cardiovascular Diseases
        11.5.3. Neuro Disorders
        11.5.4. Autoimmune Diseases
        11.5.5. Cancer
        11.5.6. GvHD
        11.5.7. Pulmonary Diseases
        11.5.8. Others
    11.6. Market Value Forecast, by Country, 2017–2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product
        11.7.2. By Type
        11.7.3. By Source of Isolation
        11.7.4. By Indication
        11.7.5. By Country

12. Europe Mesenchymal Stem Cells Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Products & Services, 2017–2031
        12.2.1. Product
            12.2.1.1. Workflow Type
            12.2.1.2. Product Type
        12.2.2. Services
    12.3. Market Value Forecast, by Type, 2017–2031
        12.3.1. Autologous
        12.3.2. Allogenic
    12.4. Market Value Forecast, by Source of Isolation, 2017–2031
        12.4.1. Bone Marrow
            12.4.1.1. Adipose
            12.4.1.2. Cord Blood
            12.4.1.3. Peripheral Blood
        12.4.2. Dental Pulp
        12.4.3. Others (lung tissue, umbilical cord tissue, etc.)
    12.5. Market Value Forecast, by Indication , 2017–2031
        12.5.1. Musculoskeletal Diseases
        12.5.2. Cardiovascular Diseases
        12.5.3. Neuro Disorders
        12.5.4. Autoimmune Diseases
        12.5.5. Cancer
        12.5.6. GvHD
        12.5.7. Pulmonary Diseases
        12.5.8. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Product
        12.7.2. By Type
        12.7.3. By Source of Isolation
        12.7.4. By Indication
        12.7.5. By Country/Sub-region
13. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Products & Services, 2017–2031
        13.2.1. Product
            13.2.1.1. Workflow Type
            13.2.1.2. Product Type
        13.2.2. Services
    13.3. Market Value Forecast, by Type, 2017–2031
        13.3.1. Autologous
        13.3.2. Allogenic
    13.4. Market Value Forecast, by Source of Isolation, 2017–2031
        13.4.1. Bone Marrow
            13.4.1.1. Adipose
            13.4.1.2. Cord Blood
            13.4.1.3. Peripheral Blood
        13.4.2. Dental Pulp
        13.4.3. Others (lung tissue, umbilical cord tissue, etc.)
    13.5. Market Value Forecast, by Indication , 2017–2031
        13.5.1. Musculoskeletal Diseases
        13.5.2. Cardiovascular Diseases
        13.5.3. Neuro Disorders
        13.5.4. Autoimmune Diseases
        13.5.5. Cancer
        13.5.6. GvHD
        13.5.7. Pulmonary Diseases
        13.5.8. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. South Korea
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Product
        13.7.2. By Type
        13.7.3. By Source of Isolation
        13.7.4. By Indication
        13.7.5. By Country/Sub-region
14. Latin America Mesenchymal Stem Cells Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Products & Services, 2017–2031
        14.2.1. Product
            14.2.1.1. Workflow Type
            14.2.1.2. Product Type
        14.2.2. Services
    14.3. Market Value Forecast, by Type, 2017–2031
        14.3.1. Autologous
        14.3.2. Allogenic
    14.4. Market Value Forecast, by Source of Isolation, 2017–2031
        14.4.1. Bone Marrow
            14.4.1.1. Adipose
            14.4.1.2. Cord Blood
            14.4.1.3. Peripheral Blood
        14.4.2. Dental Pulp
        14.4.3. Others (lung tissue, umbilical cord tissue, etc.)
    14.5. Market Value Forecast, by Indication , 2017–2031
        14.5.1. Musculoskeletal Diseases
        14.5.2. Cardiovascular Diseases
        14.5.3. Neuro Disorders
        14.5.4. Autoimmune Diseases
        14.5.5. Cancer
        14.5.6. GvHD
        14.5.7. Pulmonary Diseases
        14.5.8. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Product
        14.7.2. By Type
        14.7.3. By Source of Isolation
        14.7.4. By Indication
        14.7.5. By Country/Sub-region

15. Middle East & Africa Mesenchymal Stem Cells Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Products & Services, 2017–2031
        15.2.1. Product
            15.2.1.1. Workflow Type
            15.2.1.2. Product Type
        15.2.2. Services
    15.3. Market Value Forecast, by Type, 2017–2031
        15.3.1. Autologous
        15.3.2. Allogenic
    15.4. Market Value Forecast, by Source of Isolation, 2017–2031
        15.4.1. Bone Marrow
            15.4.1.1. Adipose
            15.4.1.2. Cord Blood
            15.4.1.3. Peripheral Blood
        15.4.2. Dental Pulp
        15.4.3. Others (lung tissue, umbilical cord tissue, etc.)
    15.5. Market Value Forecast, by Indication, 2017–2031
        15.5.1. Musculoskeletal Diseases
        15.5.2. Cardiovascular Diseases
        15.5.3. Neuro Disorders
        15.5.4. Autoimmune Diseases
        15.5.5. Cancer
        15.5.6. GvHD
        15.5.7. Pulmonary Diseases
        15.5.8. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Product
        15.7.2. By Type
        15.7.3. By Source of Isolation
        15.7.4. By Indication
        15.7.5. By Country/Sub-region

16. Competition Landscape
    16.1. Market Player - Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company, 2021
    16.3. Company Profiles
        16.3.1. Thermo Fisher Scientific, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Cytiva (Danaher Corporation)
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. FUJIFILM Irvine Scientific (FUJIFILM Corporation)
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Merck KGaA
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Lonza Group Ltd.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. STEMCELL Technologies, Inc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Takara Bio, Inc.
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Sartorius AG
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Miltenyi Biotec GmbH
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. PromoCell GmbH
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 02: Global Mesenchymal Stem Cells Market Value Share, by Products & Services, 2022

Figure 03: Global Mesenchymal Stem Cells Market Value Share, by Type, 2022

Figure 04: Global Mesenchymal Stem Cells Market Value Share, by Source of Isolation, 2022

Figure 05: Global Mesenchymal Stem Cells Market Value Share, by Indication, 2022

Figure 06: Global Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 07: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 08: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Product, 2017–2032

Figure 09: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Services, 2017–2032

Figure 10: Global Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 11: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023–2032

Figure 12: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Autologous, 2017–2032

Figure 13: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Allogenic, 2017–2032

Figure 14: Global Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 15: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023–2032

Figure 16: Global Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 17: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023–2032

Figure 18: Global Mesenchymal Stem Cells Market Value Share Analysis, by Region, 2022 and 2032

Figure 19: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Region, 2023–2032

Figure 20: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 21: North America Mesenchymal Stem Cells Market Value Share Analysis, by Country, 2022 and 2032

Figure 22: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country, 2023–2032

Figure 23: North America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 24: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 25: North America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 26: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023–2032

Figure 27: North America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 28: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023–2032

Figure 29: North America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 30: North America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023–2032

Figure 31: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 32: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 33: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023–2032

Figure 34: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 35: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 36: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 37: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023–2032

Figure 38: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 39: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023–2032

Figure 40: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 41: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023–2032

Figure 42: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 43: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 44: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023–2032

Figure 45: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 46: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 47: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 48: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023–2032

Figure 49: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 50: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023–2032

Figure 51: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 52: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023–2032

Figure 53: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 54: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 55: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023–2032

Figure 56: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 57: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 58: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 59: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Type, 2023–2032

Figure 60: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 61: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Source of Isolation, 2023–2032

Figure 62: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 63: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023–2032

Figure 64: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017–2032

Figure 65: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032

Figure 66: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023–2032

Figure 67: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032

Figure 68: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023–2032

Figure 69: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032

Figure 70: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023–2032

Figure 71: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032

Figure 72: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation, 2023–2032

Figure 73: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032

Figure 74: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023–2032

List of Tables

List of Tables

Table 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 02: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 03: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 04: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2032

Table 05: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032

Table 06: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Region, 2017–2032

Table 07: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country, 2017–2032

Table 08: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 09: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 10: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 11: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2031

Table 12: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032

Table 13: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2032

Table 14: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 15: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 16: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 17: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2031

Table 18: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032

Table 19: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2032

Table 20: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 21: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 22: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 23: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2031

Table 24: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032

Table 25: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2032

Table 26: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 27: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 28: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 29: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2031

Table 30: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032

Table 31: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2032

Table 32: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017–2032

Table 33: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017–2032

Table 34: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017–2032

Table 35: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017?2031

Table 36: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017–2032